LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 962 | 10236 | 10605 | 0.9652 | 0.9618 |
MCF 10A | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 962 | 9847 | 10605 | 0.9285 | 0.9214 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 7981 | 10605 | 0.7526 | 0.7279 |
MCF 10A | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 4396 | 10605 | 0.4146 | 0.3562 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1276 | 10605 | 0.1204 | 0.0326 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 970 | 10605 | 0.0915 | 0.0008 |
MCF 10A | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1141 | 10605 | 0.1076 | 0.0186 |
MCF 10A | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 962 | 11572 | 10605 | 1.0912 | 1.1003 |
MCF 10A | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1534 | 10605 | 0.1447 | 0.0594 |
MCF 10A | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1490 | 10605 | 0.1405 | 0.0548 |
MCF 10A | R406 | 3.33 | uM | LJP6 | 72 | hr | 962 | 7814 | 10605 | 0.7368 | 0.7106 |
MCF 10A | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 962 | 2782 | 10605 | 0.2624 | 0.1888 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 1402 | 10605 | 0.1322 | 0.0456 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 962 | 807 | 10605 | 0.0762 | -0.0160 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 962 | 628 | 10605 | 0.0593 | -0.0346 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 962 | 806 | 10605 | 0.0760 | -0.0162 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 962 | 745 | 10605 | 0.0702 | -0.0225 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 962 | 8142 | 10605 | 0.7678 | 0.7446 |
MCF 10A | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 962 | 752 | 10605 | 0.0709 | -0.0218 |
MCF 10A | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 962 | 8202 | 10605 | 0.7734 | 0.7508 |
MCF 10A | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 962 | 647 | 10605 | 0.0610 | -0.0326 |
MCF 10A | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1672 | 10605 | 0.1577 | 0.0736 |
MCF 10A | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 962 | 7811 | 10605 | 0.7365 | 0.7102 |
MCF 10A | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 10598 | 10605 | 0.9994 | 0.9993 |
MCF 10A | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 962 | 460 | 10605 | 0.0434 | -0.0520 |